The Lobby
Bills
Legislators
Votes
Newsletter
Directory
/
Bills
/
S. 1302
S. 1302 · 119th Congress · Senate
Increasing Transparency in Generic Drug Applications Act
Active
· Introduced in Senate
Introduced
Apr 3, 25
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Apr 3, 25
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending
Overview
Bill Text
1
Related Bills
8
Votes
Bill
Title
Relationship
Last Action
H.R. 7148
119th Congress
Consolidated Appropriations Act, 2026
Became Public Law No: 119-75.
Related bill
by CRS
Feb 3, 2026
H.R. 7148
119th Congress
Consolidated Appropriations Act, 2026
Became Public Law No: 119-75.
Related bill
by CRS
Feb 3, 2026
S. 891
119th Congress
Bipartisan Health Care Act
Introduced in Senate
Related bill
by CRS
Mar 6, 2025
S. 891
119th Congress
Bipartisan Health Care Act
Introduced in Senate
Related bill
by CRS
Mar 6, 2025
H.R. 1843
119th Congress
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Introduced in House
Related bill
by CRS
Mar 5, 2025
H.R. 1843
119th Congress
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Introduced in House
Related bill
by CRS
Mar 5, 2025
H.R. 1768
119th Congress
Lower Costs for Everyday Americans Act
Introduced in House
Related bill
by CRS
Mar 3, 2025
H.R. 1768
119th Congress
Lower Costs for Everyday Americans Act
Introduced in House
Related bill
by CRS
Mar 3, 2025